- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Newton starts sowing second fund
Newton Biocapital’s first fund was instrumental in establishing four spinouts and it has raised $57m towards its $172m goal for its second vehicle.
Feb 15, 2022Deals: February 14, 2022
Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Feb 14, 2022Analysis: D-Wave rides a reverse merger
The NEC-backed quantum computing system developer will list on the New York Stock Exchange. The company is part of the budding quantum computing tech space in which corporates are taking increasing interest.
Feb 14, 2022NFL's 32 Equity goes quiet on big day
Departure of venture unit head, Kevin LaForce, leaves 32 Equity in apparent limbo.
Feb 13, 2022Daily Deal Round Up: February 11, 2022
Cybersecurity technology producer Salt Security nabbed $140m in a CapitalG-led round while healthcare unicorn Thirty Madison merged with Comcast-backed Nurx.
Feb 11, 2022Exits: February 11, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Feb 11, 2022Deals: February 11, 2022
Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Feb 11, 2022UZH and ETH formalise Wyss collaboration
Aiming to provide a long-term future to their Wyss Zurich Translational Center, University of Zurich and ETH Zurich have set up the non-profit Wyss Zurich Foundation.
Feb 11, 2022Seismic Therapeutic emerges with $101m
Harvard’s serial entrepreneur Timothy Springer has formally launched his latest venture with a $101m series A round backed by GV.
Feb 11, 2022Daily Deal Round Up: February 10, 2022
Data analytics platform developer Starburst raised $250m in a Salesforce-backed round valuing it above $3.3bn while SoftBank co-led a $140m round for small molecule drug developer Ventus.
Feb 10, 2022Seismic Therapeutic emerges with $101m
Alphabet’s GV subsidiary was among the participants in the immunology drug development platform’s first publicly disclosed round.
Feb 10, 2022Exits: February 10, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Feb 10, 2022Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


